SCHEMBL8201381

SCHEMBL8201381

c1ccc2[nH]c(CN(CCN(Cc3nc4ccccc4[nH]3)Cc3nc4ccccc4[nH]3)Cc3nc4ccccc4[nH]3)nc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 1.00
DDAH1 O94760 1/20 0.59
POLB P06746 1/20 0.59
GAA P10253 1/20 0.56
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
TDP1 Q9NUW8 1/20 0.54
PKM P14618 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
TP53 P04637 1/20 0.51
TSHR P16473 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
CHRM1 P11229 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20677816 0.93 BCHE (0.87) BCHEDDAH1POLBGAANPC1
SCHEMBL20677807 0.93 BCHE (0.87) BCHEDDAH1POLBGAANPC1
SCHEMBL370724 0.92 BCHE (0.86) BCHEDDAH1POLBGAANPC1
SCHEMBL29550341 0.92 BCHE (0.86) BCHEDDAH1POLBGAANPC1
Magnesium SCHEMBL30119882 0.91 BCHE (0.83) BCHEDDAH1POLBGAANPC1
SCHEMBL1333203 0.91 BCHE (0.82) BCHEDDAH1POLBGAANPC1
SCHEMBL8207504 0.91 BCHE (0.82) BCHEDDAH1POLBGAANPC1
SCHEMBL24247365 0.90 BCHE (0.81) BCHEDDAH1POLBGAANPC1
SCHEMBL5181863 0.90 BCHE (0.81) BCHEDDAH1POLBGAANPC1
SCHEMBL8201331 0.89 BCHE (0.79) BCHEDDAH1POLBGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4207389-A1 POSITIVE ELECTRODE SLURRY, POSITIVE ELECTRODE PLATE, LITHIUM ION BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE Contemporary Amperex Technology Co., Limited (CN) 2023-07-05 EP claimed
US-20230138600-A1 POSITIVE ELECTRODE SLURRY, POSITIVE ELECTRODE PLATE, LITHIUM-ION BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2023-05-04 US claimed
EP-3307941-B1 OXIDATIVE METHOD CATEXEL TECH LIMITED (GB) 2021-03-24 EP claimed
US-12542279-B2 Positive electrode slurry, positive electrode plate, lithium-ion battery, battery module, battery pack, and electrical device CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2026-02-03 US disclosed
EP-4207389-A1 POSITIVE ELECTRODE SLURRY, POSITIVE ELECTRODE PLATE, LITHIUM ION BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE Contemporary Amperex Technology Co., Limited (CN) 2023-07-05 EP disclosed
US-20230138600-A1 POSITIVE ELECTRODE SLURRY, POSITIVE ELECTRODE PLATE, LITHIUM-ION BATTERY, BATTERY MODULE, BATTERY PACK, AND ELECTRICAL DEVICE CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) 2023-05-04 US disclosed
CN-103204882-A Multi-benzimidazole iron complex, as well as preparation method and application thereof CHINESE ACAD INST CHEMISTRY 2013-07-17 CN disclosed
US-6022490-A FOR ACTIVATING PEROXY BLEACH LEVER BROTHERS COMPANY (US) 2000-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12542279-B2 Positive electrode slurry, positive electrode plate, lithium-ion battery, battery module, battery pack, and electrical device LBR, CACNA1E, CACNA2D4 BCHE 3449/4885DDAH1 4815/4885POLB 2634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.